European Healthtech startup funding raised during October 2024.
In October 2024, 25 European Healthtech companies raised a combined €428M across 25 funding rounds, up 33.4% versus October 2023. UK led by capital raised, and Asabys Partners was the most active investor. Data as of 9 Jul 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Agomab Therapeutics | Series D+ | Oct 2024 | €83M |
| Nuclera | Series A | Oct 2024 | €69M |
| Basecamp Research | Series B | Oct 2024 | €55M |
| Inbrain Neuroelectronics | Series B |
| Oct 2024 |
| €46M |
| Aignostics | Series B | Oct 2024 | €32M |
| Enara Bio | Series B | Oct 2024 | €29M |
| Lumicks | Debt | Oct 2024 | €20M |
| Lymphatica Medtech | Other | Oct 2024 | €18M |
| Shift Bioscience | Seed | Oct 2024 | €15M |
| Semble | Series B | Oct 2024 | €14M |
| Cirdan | Other | Oct 2024 | €9.0M |
| Generare | Seed | Oct 2024 | €5.0M |
| Confocal.nl | Other | Oct 2024 | €5.0M |
| Homedoctor | Other | Oct 2024 | €4.5M |
| Scalpel AI | Other | Oct 2024 | €4.4M |
